Abbott Laboratories (ABT)
3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS
The broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these medical stocks fit the bill ahead of their Q2 reports.
Sell ABT Stock Ahead Of Its Q2 Earnings?
Abbott Laboratories (NYSE:ABT) is scheduled to announce its second-quarter earnings on Thursday, July 17, 2025. For traders who focus on events, examining the historical reactions of the stock to earnings announcements can offer useful insights.
Countdown to Abbott (ABT) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Abbott (ABT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
ABT to Report Q2 Earnings: CGM and Cardiac Devices in Focus
Abbott eyes Q2 growth with strong CGM momentum, cardiac device wins and resilient performance across key segments.
Abbott (ABT) Suffers a Larger Drop Than the General Market: Key Insights
Abbott (ABT) reached $132.02 at the closing of the latest trading day, reflecting a -1.18% change compared to its last close.
Abbott (ABT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Abbott (ABT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ABT's FreeStyle Libre 3 Plus Now Available in Canada: Stock to Rise?
Abbott debuts FreeStyle Libre 3 Plus in Canada, enhancing diabetes care with the world's smallest glucose sensor.
Should You Buy Abbott Stock At $135?
Abbott Laboratories (NYSE:ABT) has greatly exceeded the broader S&P 500 index this year, with its stock price increasing by 18% compared to the S&P 500's 6% rise. This strong performance is due to the company's solid quarterly results and positive future forecasts.
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note
In the closing of the recent trading day, Abbott (ABT) stood at $134.11, denoting a -1.58% move from the preceding trading day.
Abbott (ABT) Upgraded to Buy: Here's What You Should Know
Abbott (ABT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion
ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.
